Drug reaction with eosinophilia and systemic symptoms (DRESS) successfully treated with tumor necrosis factor-α inhibitor
- PMID: 28752124
- PMCID: PMC5518151
- DOI: 10.1016/j.jdcr.2017.05.006
Drug reaction with eosinophilia and systemic symptoms (DRESS) successfully treated with tumor necrosis factor-α inhibitor
Keywords: DRESS, drug reaction with eosinophilia and systemic symptoms; Drug reaction with eosinophilia and systemic symptoms; SJS, Stevens Johnson syndrome; TEN, toxic epidermal necrolysis; TNF, tumor necrosis factor; erythematous maculopapular rash; lithium carbonate; recombinant human TNF receptor-IgG fusion protein; treatment; tumor necrosis factor-α inhibitor.
Figures
Similar articles
-
Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.Cornea. 2016 Jun;35(6):888-91. doi: 10.1097/ICO.0000000000000845. Cornea. 2016. PMID: 27078005
-
Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.J Dermatol Sci. 2014 Feb;73(2):101-9. doi: 10.1016/j.jdermsci.2013.10.003. Epub 2013 Oct 22. J Dermatol Sci. 2014. PMID: 24268988
-
Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.Clin Dermatol. 2005 May-Jun;23(3):311-4. doi: 10.1016/j.clindermatol.2005.02.001. Clin Dermatol. 2005. PMID: 15896547
-
Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.Clin Dermatol. 2015 Sep-Oct;33(5):538-41. doi: 10.1016/j.clindermatol.2015.05.005. Epub 2015 May 27. Clin Dermatol. 2015. PMID: 26321400 Review.
-
Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome.World J Clin Cases. 2019 Mar 26;7(6):705-716. doi: 10.12998/wjcc.v7.i6.705. World J Clin Cases. 2019. PMID: 30968035 Free PMC article. Review.
Cited by
-
Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer.J Am Acad Dermatol. 2021 Feb;84(2):273-282. doi: 10.1016/j.jaad.2020.03.010. Epub 2020 Mar 12. J Am Acad Dermatol. 2021. PMID: 32171811 Free PMC article.
-
Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.J Immunol Res. 2018 Mar 18;2018:5163129. doi: 10.1155/2018/5163129. eCollection 2018. J Immunol Res. 2018. PMID: 29744372 Free PMC article. Review.
-
The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids.World Allergy Organ J. 2024 Jul 20;17(8):100935. doi: 10.1016/j.waojou.2024.100935. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39156598 Free PMC article. Review.
-
Etanercept leads to a rapid recovery of a Dabrafenib-/Trametinib-associated toxic epidermal necrolysis-like severe skin reaction.Skin Health Dis. 2022 Nov 5;3(1):e185. doi: 10.1002/ski2.185. eCollection 2023 Feb. Skin Health Dis. 2022. PMID: 36751314 Free PMC article.
-
When fever is more than infection: two cases of vancomycin-induced drug reaction with eosinophilia and systemic symptoms (DRESS).BMJ Case Rep. 2021 Jan 7;14(1):e238006. doi: 10.1136/bcr-2020-238006. BMJ Case Rep. 2021. PMID: 33414117 Free PMC article.
References
-
- Gubinelli E., Canzona F., Tonanzi T., Raskovic D., Didona B. Toxic epidermal necrolysis successfully treated with etanercept. J Dermatol. 2009;36:150–153. - PubMed
-
- Hunger R.E., Hunziker T., Buettiker U., Braathen L.R., Yawalkar N. Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment. J Allergy Clin Immunol. 2005;116:923–924. - PubMed
-
- Kardaun S.H., Sidoroff A., Valeyrie-Allanore L. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609–611. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources